title: Fever in pulmonary embolism.
abstract: This study was planned to investigate the characteristics of clinical and laboratory findings of patients with fever diagnosed as pulmonary embolism (PE) in comparison with PE patients without fever and patients with community-acquired pneumonia (CAP). Thirty-nine PE patients with fever without other identifiable causes (18 received antibiotics and 21 did not receive antibiotics) (study groups) were included in the study. 22 patients with PE without fever and 21 patients diagnosed with CAP were retrospectively selected as control groups. Daily peak body temperature, risk factors for PE, symptoms, and physical and laboratory findings at admission were recorded. Patients with CAP demonstrated higher body temperature than PE patients with fever (38.5+/-0.6 versus 37.8+/-0.6 degrees C, P=0.0001). Fever patterns were similar between the three groups of patients who had fever. The leukocyte count and the erythrocyte sedimentation rate (ESR) were slightly higher in the group of PE with fever versus PE without fever (11,465.6+/-4229.4/mm, 51.1+/-34.7/mm/h versus 10,777.3+/-4927.6/mm, 35.2+/-30.1/mm/h, respectively) (P>0.05). The group of CAP showed significantly highest values of leukocyte count and ESR (15,490.5+/-5606.3/mm, 69.1+/-35.9/mm per h, respectively) (P<0.05). This study suggested that fever might accompany with PE. The presence of slight leukocytosis and increased ESR may not securely differentiate PE patients with fever from patients with CAP.
authors.affiliation: Department of Pulmonary Medicine, Gazi University School of Medicine, and Department of Nuclear Medicine, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey. nkokturk@gazi.edu.tr
authors.forename: Nurdan
authors.initials: N
authors.lastname: Kokturk
authors.forename: Nalan
authors.initials: N
authors.lastname: Demir
authors.forename: I Kivilcim
authors.initials: IK
authors.lastname: Oguzulgen
authors.forename: Koray
authors.initials: K
authors.lastname: Demirel
authors.forename: Numan
authors.initials: N
authors.lastname: Ekim
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001799:Blood Sedimentation; D001831:Body Temperature; D017714:Community-Acquired Infections / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D005334:Fever / Q000150:complications* / Q000175:diagnosis; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy; D011859:Radiography; D015898:Tomography Scanners, X-Ray Computed
chemical_list: D000900:Anti-Bacterial Agents